Cargando…

Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea

Chronic hepatitis B (CHB) affects over 250 million people worldwide. In Papua New Guinea, the prevalence of CHB has been estimated to be over 8%, and it is a leading cause of death. To address this problem, an alliance was formed between the government of Oro Province, a large private employer and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Alice Unah, Mair, Luke, Kevin, Bob, Gandi, Lily, Tarumuri, Olive, Lee, Caroline, Huntley, Sue, Hilmers, David Carl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152820/
https://www.ncbi.nlm.nih.gov/pubmed/34046236
http://dx.doi.org/10.5365/wpsar.2020.11.3.001
Descripción
Sumario:Chronic hepatitis B (CHB) affects over 250 million people worldwide. In Papua New Guinea, the prevalence of CHB has been estimated to be over 8%, and it is a leading cause of death. To address this problem, an alliance was formed between the government of Oro Province, a large private employer and an Australian nongovernmental organization, which established a CHB test and treatment programme. Between 2014 and 2019, rapid hepatitis B surface antigen testing was performed on 4068 individuals in Oro Province. The crude prevalence rate was 12.98% and was significantly higher in males (15.26%) than females (10.94%) (P < 0.001). The rate was 4.72% among children aged 10 years and under, 12.81% among women of childbearing age (19–35 years) and 18.48% among health-care workers. These results indicate that the rates of vaccination at birth and later among women of childbearing age and health-care workers must be improved to prevent transmission of CHB.